GSTM1 and Thrombocytopenia: These factors may modulate bone marrow function during linezolid treatment, potentially enhancing or diminishing its myelosuppressive effects (Veerman et al., 2023).While this study primarily focused on thrombocytopenia, other potential confounding factors influence Hb may not have been fully adjusted for.